These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11361371)

  • 21. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA; McGrath P; Smith B; Houston T
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.
    Davidkin I; Valle M
    Vaccine; 1998 Dec; 16(20):2052-7. PubMed ID: 9796064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
    Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
    J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.
    Fowlkes A; Witte D; Beeler J; Audet S; Garcia P; Curns A; Yang C; Fudzulani R; Broadhead R; Bellini WJ; Cutts F; Helfand RF
    J Infect Dis; 2011 Jul; 204 Suppl 1():S149-57. PubMed ID: 21666156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization status of children born to human immunodeficiency virus (HIV)-infected mothers in two Texas cities.
    Schulte JM; Burkham S; Squires JE; Doran T; Hamaker DW; Pelosi J; Graper J; Davis R; Caldwell MB
    South Med J; 2000 Jan; 93(1):48-52. PubMed ID: 10653065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses to measles immunization in children infected with human immunodeficiency virus.
    Rudy BJ; Rutstein RM; Pinto-Martin J
    J Pediatr; 1994 Jul; 125(1):72-4. PubMed ID: 8021790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.
    Moss WJ; Scott S; Mugala N; Ndhlovu Z; Beeler JA; Audet SA; Ngala M; Mwangala S; Nkonga-Mwangilwa C; Ryon JJ; Monze M; Kasolo F; Quinn TC; Cousens S; Griffin DE; Cutts FT
    J Infect Dis; 2007 Aug; 196(3):347-55. PubMed ID: 17597448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines.
    Khalil M; Poltera AA; al-Howasi M; Herzog C; Gerike E; Wegmüller B; Glück R
    Trans R Soc Trop Med Hyg; 1999; 93(2):214-9. PubMed ID: 10450452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunological efficacy of the combined vaccine Trimovax intended for the prevention of measles, mumps and rubella].
    Samoĭlovich EO; Kapustik LA; Fel'dman EV; Ermolovich MA; Svirchevskaia EIu; Titov LP; Zakharenko DF; Belova EIu; Chernovetskiĭ MA; Korostik TS
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):36-40. PubMed ID: 9783398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G; Peña B; Marimón JM; Pérez-Trallero E
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM; Nielsen K; Garakian A; Cherry JD
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
    Flynn JT; Frisch K; Kershaw DB; Sedman AB; Bunchman TE
    Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles and rubella antibody response after measles-mumps-rubella vaccination in children with afebrile upper respiratory tract infection.
    Ratnam S; West R; Gadag V
    J Pediatr; 1995 Sep; 127(3):432-4. PubMed ID: 7658276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaccine coverage and levels of protection with triple viral vaccine in a children population].
    Sánchez Serrano LP; Corcuera MT; Molina MP; de Miguel C; Lozano J; Oñorbe JA; Barberá G
    Enferm Infecc Microbiol Clin; 1990; 8(6):384-7. PubMed ID: 2081176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination.
    Lerman SJ; Bollinger M; Brunken JM
    Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey.
    McLaughlin M; Thomas P; Onorato I; Rubinstein A; Oleske J; Nicholas S; Krasinski K; Guigli P; Orenstein W
    Pediatrics; 1988 Aug; 82(2):229-33. PubMed ID: 3399296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
    Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF
    Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.